Old Well Partners, LLC Aldeyra Therapeutics, Inc. Transaction History

Old Well Partners, LLC

  • $45.6 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$10.44 - $14.85 $245,204 - $348,781
-23,487 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$6.53 - $14.42 $153,370 - $338,682
23,487 New
23,487 $279,000
Q4 2020

Feb 16, 2021
SELL
$6.31 - $8.13 $110,898 - $142,884
-17,575 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$4.0 - $7.53 $70,300 - $132,339
17,575 New
17,575 $130,000

Others Institutions Holding ALDX

# of Institutions
117
Shares Held
36.4M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $283M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Old Well Partners, LLC Portfolio

Follow Old Well Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Well Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email